法律 发表于 2025-3-30 09:45:11
Epidemiology of Colorectal Cancer,rican Cancer Society, 147,950 new cases and 53,200 deaths are expected. The incidence of CRC has grown globally, especially in developing countries. The driving factors for CRC incidence are obesity, unhealthy food habits, smoking, and alcohol consumptions. Additionally, unmodifiable factors include机密 发表于 2025-3-30 13:47:53
http://reply.papertrans.cn/23/2297/229657/229657_52.pngcolony 发表于 2025-3-30 20:01:19
http://reply.papertrans.cn/23/2297/229657/229657_53.png进步 发表于 2025-3-30 22:03:57
Role of NMR Metabolomics and MR Imaging in Colon Cancer, out by using procedures such as colonoscopy, sigmoidoscopy, fecal occult blood test, and virtual colonoscopy. These screening methods have some limitations like invasiveness and low sensitivity and specificity. Nuclear magnetic resonance (NMR) metabolomics may play an important role in colon cancerNICE 发表于 2025-3-31 03:58:42
http://reply.papertrans.cn/23/2297/229657/229657_55.pngPalliation 发表于 2025-3-31 08:03:15
http://reply.papertrans.cn/23/2297/229657/229657_56.pngmighty 发表于 2025-3-31 10:07:56
Exosomal Biomarkers in Colorectal Cancer,at gradually develops with the cumulative effects of genetic and epigenetic alterations, which changes the normal colon mucosal layer into invasive form. Recent research interest in CRC relies on the identification of specific biomarkers for early disease diagnosis, adopting better treatment modalitPreamble 发表于 2025-3-31 17:20:40
Biomarkers as Putative Therapeutic Targets in Colorectal Cancer,cinoma, which is the cancer of the cells that lines the inner tissue of the colon and rectum. CRC is highly heterogeneous and known to undergo a series of molecular alterations throughout the natural course of the disease. As our knowledge regarding the CRC carcinogenesis advances, it is indispensaboccurrence 发表于 2025-3-31 21:36:10
http://reply.papertrans.cn/23/2297/229657/229657_59.png真繁荣 发表于 2025-4-1 00:18:11
Short-Chain Fatty Acids as Therapeutic Agents in Colon Malignancies,he detrimental effects of neoplastic cells have been implemented in preclinical and clinical settings, these transformed cells display aggressive and recalcitrant behaviour during progression as well as treatment. Natural metabolites of microbial origin have recently attracted the biomedical investi